To better understand how COVID-19 affects the BBB, we analyzed two independent biomarkers of astrocytes, astrocyte-derived extracellular vesicles (EVs) and S100B, in plasma samples obtained during the acute infection (baseline), and 4, 8, and 12 months after hospitalization for COVID-19. Here, S100B is linked to COVID-19.